339536-82-2 Usage
Uses
Used in Pharmaceutical Industry:
Ethyl 2-(1,8-naphthyridin-2-yl)acetate is used as a chemical intermediate for the synthesis of various pharmaceutical products. Its role in the development of new drugs is crucial, as it can be incorporated into the molecular structures of potential therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical sector, ethyl 2-(1,8-naphthyridin-2-yl)acetate is utilized as an intermediate in the production of agrochemicals, contributing to the development of effective solutions for pest control and crop protection.
Used in Antiviral Applications:
Ethyl 2-(1,8-naphthyridin-2-yl)acetate is employed as an antiviral agent, leveraging its potential biological activities to combat viral infections. Its antiviral properties are of interest in the development of treatments for various viral diseases.
Used in Antibacterial Applications:
ethyl 2-(1,8-naphthyridin-2-yl)acetate is also used as an antibacterial agent, given its ability to inhibit bacterial growth. Its potential use in the development of new antibiotics is significant, particularly in addressing the growing issue of antibiotic resistance.
Used in Research and Development:
Ethyl 2-(1,8-naphthyridin-2-yl)acetate is utilized in research and development efforts to explore its properties and potential applications further. Its role in scientific studies is essential for understanding its mechanisms of action and identifying new uses in medicine and other fields.
Check Digit Verification of cas no
The CAS Registry Mumber 339536-82-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,9,5,3 and 6 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 339536-82:
(8*3)+(7*3)+(6*9)+(5*5)+(4*3)+(3*6)+(2*8)+(1*2)=172
172 % 10 = 2
So 339536-82-2 is a valid CAS Registry Number.
339536-82-2Relevant academic research and scientific papers
Penning, Thomas D.,Khilevich, Albert,Chen, Barbara B.,Russell, Mark A.,Boys, Mark L.,Wang, Yaping,Duffin, Tiffany,Engleman, V. Wayne,Finn, Mary Beth,Freeman, Sandra K.,Hanneke, Melanie L.,Keene, Jeffery L.,Klover, Jon A.,Nickols, G. Allen,Nickols, Maureen A.,Rader, Randall K.,Settle, Steven L.,Shannon, Kristen E.,Steininger, Christina N.,Westlin, Marisa M.,Westlin, William F.
, p. 3156 - 3161 (2006)
We describe a series of pyrazole and isoxazole analogs as antagonists of the αvβ3 receptor. Compounds showed low to sub-nanomolar potency against αvβ3, as well as good selectivity against αIIbβ3
